| Company/Division name | INCOG BioPharma |
| Parent company | INCOG BioPharma |
| Type of work | Manufacturing |
| Reshoring category: | Reshoring |
| Total number of jobs (added or to be added): | 1000 |
| Year reshoring announced: | 2026 |
| Year reshoring implemented or to be implemented: | 2030 |
| Capital investment ($): | 200 |
| State(s) reshored to: | IN |
| If relevant, work nearshored to: | - |
| Industry(ies): | Chemicals |
| Product(s) reshored | pharma |
| What domestic positive factors made reshoring more attractive? | Customization/Flexibility, Impact on domestic economy, Proximity to customers/market, Skilled workforce availability/training |
